CRVO: CervoMed Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 83.20
Enterprise Value ($M) 75.45
Book Value ($M) 45.64
Book Value / Share 5.53
Price / Book 1.82
NCAV ($M) 45.56
NCAV / Share 5.52
Price / NCAV 1.83

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.99
Return on Equity (ROE) -1.25

Liquidity (mrq)
Quick Ratio 15.04
Current Ratio 15.04

Balance Sheet (mrq) ($M)
Current Assets 48.81
Assets 48.88
Liabilities 3.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
7 days ago 13G AWM Investment Company, Inc. 9.90
04-11 13G Ra Capital Management, L.p. 9.99
03-06 13G/A AI EIPP Holdings LLC 0.74 -90.06
02-28 13D/A Boger Joshua S 17.10 88.36

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-20 14,770 59,448 24.85
2024-11-19 24,226 99,317 24.39
2024-11-18 14,187 45,406 31.24
2024-11-15 18,048 65,285 27.64

(click for more detail)

Similar Companies
CRBP – Corbus Pharmaceuticals Holdings, Inc. CRDF – Cardiff Oncology, Inc.
CRIS – Curis, Inc. CSBR – Champions Oncology, Inc.
CSCI – COSCIENS Biopharma Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.